Thaçi, D., Armstrong, A., Lebwohl, M., Blauvelt, A., Paul, C., Puig, L., Wang, M., Vanvoorden, V., Madden, C., Wiegratz, S., Deherder, D. and Gordon, K. (2022) “Maintenance of bimekizumab efficacy through 2 years in patients with moderate to severe plaque psoriasis: Pooled results from five phase 3/3b trials”, SKIN The Journal of Cutaneous Medicine, 6(6), p. s71. doi: 10.25251/skin.6.supp.71.